TickrTrends AMPH fair value analysis

A Look at Amphastar Pharmaceuticals Inc (AMPH) After 3.3% Gain -- GF Value $35.96 vs Price $23.74

gurufocus.com · 2026-09-03

On September 02, 2026, Amphastar Pharmaceuticals Inc (AMPH) shares rose 3.3% to $23.74. The stock is currently trading within a 52-week range of $16.65 to $31.2

TickrTrends take: Amphastar Pharmaceuticals trades below its GF Value estimate, which aligns with TickrTrends' undervalued assessment for this Healthcare sector company. The gap between the current price and estimated intrinsic value suggests the stock may warrant attention from investors focused on valuation metrics. Readers tracking AMPH should monitor whether the company's fundamentals support a closer convergence toward the higher valuation benchmark over time.

Read the full story at gurufocus.com →

Is AMPH undervalued? See TickrTrends' fair value analysis →